Total Payments
$262,720
2024 Payments
$2,770
Companies
96
Transactions
1,323
Medicare Patients
8,844
Medicare Billing
$2.6M
Payment Breakdown by Category
Other$162,523 (61.9%)
Consulting$30,672 (11.7%)
Research$27,736 (10.6%)
Food & Beverage$24,309 (9.3%)
Travel$17,123 (6.5%)
Education$357.92 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $162,523 | 86 | 61.9% |
| Consulting Fee | $30,672 | 8 | 11.7% |
| Unspecified | $27,736 | 4 | 10.6% |
| Food and Beverage | $24,309 | 1,125 | 9.3% |
| Travel and Lodging | $17,123 | 87 | 6.5% |
| Education | $357.92 | 13 | 0.1% |
Payments by Type
General
$234,984
1,319 transactions
Research
$27,736
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $74,920 | 157 | $0 (2024) |
| Allergan, Inc. | $45,378 | 126 | $0 (2022) |
| GENZYME CORPORATION | $39,369 | 92 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $28,152 | 28 | $0 (2024) |
| EMD Serono, Inc. | $23,967 | 57 | $0 (2023) |
| Acorda Therapeutics, Inc | $19,731 | 44 | $0 (2024) |
| Kyowa Kirin, Inc. | $9,685 | 11 | $0 (2022) |
| ABBVIE INC. | $6,887 | 65 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $960.93 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $915.20 | 59 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,770 | 100 | MDD US Operations, LLC ($738.17) |
| 2023 | $3,142 | 114 | ABBVIE INC. ($1,030) |
| 2022 | $7,797 | 135 | ABBVIE INC. ($5,495) |
| 2021 | $18,194 | 149 | Allergan, Inc. ($15,569) |
| 2020 | $33,327 | 111 | EMD Serono, Inc. ($12,083) |
| 2019 | $68,382 | 258 | Biogen, Inc. ($22,411) |
| 2018 | $70,593 | 234 | Biogen, Inc. ($28,217) |
| 2017 | $58,516 | 222 | Biogen, Inc. ($17,208) |
All Payment Transactions
1,323 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $27.69 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $41.41 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neurology | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PAIN | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: EPILEPSY | ||||||
| 10/22/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: PAIN | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Rare Disease | ||||||
| 09/17/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-048 | ACADIA Pharmaceuticals Inc | $16,350 | 3 |
| ACP-103-015 | ACADIA Pharmaceuticals Inc | $11,386 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,952 | 88,510 | $2.5M | $636,218 |
| 2022 | 33 | 2,320 | 89,058 | $2.7M | $688,558 |
| 2021 | 30 | 2,249 | 82,398 | $2.4M | $646,621 |
| 2020 | 29 | 2,323 | 87,181 | $2.1M | $640,005 |
Total Patients
8,844
Total Services
347,147
Medicare Billing
$2.6M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 109 | 71,700 | $1.3M | $350,557 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 552 | 760 | $263,720 | $62,278 | 23.6% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 43 | 14,000 | $206,500 | $54,889 | 26.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 75 | 227 | $151,678 | $27,137 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 164 | 197 | $95,545 | $22,960 | 24.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 123 | 346 | $75,774 | $19,262 | 25.4% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 40 | 110 | $70,840 | $13,969 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 87 | 87 | $51,678 | $12,867 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 106 | 106 | $47,594 | $12,346 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 223 | $54,412 | $11,837 | 21.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 36 | 93 | $37,107 | $8,745 | 23.6% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 27 | 115 | $28,750 | $7,707 | 26.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 18 | 74 | $28,046 | $6,994 | 24.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 68 | 73 | $25,331 | $5,333 | 21.1% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 18 | 43 | $20,210 | $4,797 | 23.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 13 | 44 | $17,996 | $4,472 | 24.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 33 | $8,976 | $2,308 | 25.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $7,200 | $1,711 | 23.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 29 | $4,350 | $1,143 | 26.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 21 | 32 | $21,376 | $992.97 | 4.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 19 | $4,655 | $974.68 | 20.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 38 | 38 | $5,323 | $966.46 | 18.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 71 | $1,420 | $596.40 | 42.0% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 33 | 45 | $8,235 | $569.79 | 6.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 13 | $1,846 | $482.40 | 26.1% |
About Dr. James Patton, MD
Dr. James Patton, MD is a Neurology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518945690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Patton, MD has received a total of $262,720 in payments from pharmaceutical and medical device companies, with $2,770 received in 2024. These payments were reported across 1,323 transactions from 96 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($162,523).
As a Medicare-enrolled provider, Patton has provided services to 8,844 Medicare beneficiaries, totaling 347,147 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Asheville, NC
- Active Since 01/09/2006
- Last Updated 09/21/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1518945690
Products in Payments
- AUBAGIO (Drug) $39,047
- BOTOX (Biological) $37,695
- TECFIDERA (Drug) $36,132
- TYSABRI (Biological) $30,092
- NUPLAZID (Drug) $28,152
- INBRIJA (Drug) $17,560
- Mavenclad (Drug) $12,083
- Mavenclad (Biological) $11,596
- BOTOX (Drug) $10,214
- NOURIANZ (Drug) $9,685
- BOTOX NEURO REHAB (Drug) $3,326
- Gocovri (Drug) $738.17
- APTIOM (Drug) $578.59
- TROKENDI XR (Drug) $526.30
- Aimovig (Biological) $477.40
- Fycompa (Drug) $408.16
- Briviact (Drug) $388.77
- AJOVY (Drug) $374.27
- RYTARY (Drug) $367.09
- KESIMPTA (Drug) $340.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Asheville
Robert Armstrong, Md, MD
Neurology — Payments: $142,313
Neurology $142,313
Dr. Matthew Engelbrecht, M.d, M.D
Neurology — Payments: $51,456
Neurology $51,456
Dr. Lei Lu
Neurology — Payments: $2,910
Neurology $2,910
Alexander Schneider, M.d, M.D
Neurology — Payments: $1,133
Neurology $1,133
Anna-Marieta Moise, M.d, M.D
Neurology — Payments: $1,118
Neurology $1,118
Dr. Alendia Hartshorn, Md, MD
Neurology — Payments: $720.83
Neurology $720.83